NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Virbac SA (PA: VIRP)
VIRP Technical Analysis
4
As on 17th Oct 2025 VIRP STOCK Price closed @ 333.50 and we RECOMMEND Sell for LONG-TERM with Stoploss of 336.71 & Strong Sell for SHORT-TERM with Stoploss of 351.24 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VIRPSTOCK Price
Open | 338.50 | Change | Price | % |
High | 339.50 | 1 Day | 22.50 | 7.23 |
Low | 329.50 | 1 Week | 15.50 | 4.87 |
Close | 333.50 | 1 Month | 9.50 | 2.93 |
Volume | 12495 | 1 Year | -26.00 | -7.23 |
52 Week High 400.00 | 52 Week Low 280.60 |
PA France Most Active Stocks
ALVER | 0.00 | % |
ALADO | 0.00 | % |
FTI | 5.91 | -1.66% |
VIEDS | 0.72 | 4.35% |
ALBOO | 0.00 | % |
WLN | 2.16 | -4.42% |
ACA | 16.49 | -2.48% |
CGG | 0.69 | -2.82% |
ORA | 14.34 | 1.77% |
ALHYG | 0.01 | 0.00% |
PA France Top Gainers Stocks
PA France Top Losers Stocks
VIRP Daily Charts |
VIRP Intraday Charts |
Whats New @ Bazaartrend |
VIRP Free Analysis |
|
VIRP Important Levels Intraday
RESISTANCE | 352.77 |
RESISTANCE | 346.59 |
RESISTANCE | 342.77 |
RESISTANCE | 338.95 |
SUPPORT | 328.05 |
SUPPORT | 324.23 |
SUPPORT | 320.41 |
SUPPORT | 314.23 |
VIRP Forecast October 2025
4th UP Forecast | 430.81 |
3rd UP Forecast | 399.6 |
2nd UP Forecast | 380.31 |
1st UP Forecast | 361.02 |
1st DOWN Forecast | 305.98 |
2nd DOWN Forecast | 286.69 |
3rd DOWN Forecast | 267.4 |
4th DOWN Forecast | 236.19 |
VIRP Weekly Forecast
4th UP Forecast | 371.08 |
3rd UP Forecast | 359.03 |
2nd UP Forecast | 351.58 |
1st UP Forecast | 344.13 |
1st DOWN Forecast | 322.87 |
2nd DOWN Forecast | 315.42 |
3rd DOWN Forecast | 307.97 |
4th DOWN Forecast | 295.92 |
VIRP Forecast2025
4th UP Forecast | 623.13 |
3rd UP Forecast | 530.24 |
2nd UP Forecast | 472.83 |
1st UP Forecast | 415.41 |
1st DOWN Forecast | 251.59 |
2nd DOWN Forecast | 194.17 |
3rd DOWN Forecast | 136.76 |
4th DOWN Forecast | 43.87 |
Virbac SA ( PA France Symbol : VIRP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VIRP Other Details
Segment | EQ | |
Market Capital | 3553700096.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-General | |
Offical website | > echo $website ; ?> |
VIRP Address
![]() |
VIRP Latest News
VIRP Business Profile
Virbac SA manufactures and sells pharmaceutical, biological, nutritional, and diagnostic products for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, and the Middle East and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. Virbac SA was founded in 1968 and is headquartered in Carros, France. Address: 13e rue LID - BP 27, Carros, France, 06511
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service